# Seluna Secures €752k for Paediatric Sleep AI Diagnostics
_MedTech startup Seluna secured nearly €752k in funding, led by Gabriel Investment Syndicate. The investment, with contributions from Scottish Enterprise, will advance its AI-powered diagnostics for paediatric sleep disorders. This technology aims to tackle the underdiagnosis of childhood sleep apnoea, a condition..._
**Published:** 2025-08-28
**Source:** https://www.startuphub.ai/ai-news/funding-round/2025/seluna-secures-e752k-for-paediatric-sleep-ai-diagnostics
---
[Seluna](https://selunaofficial.com/collections/all), a Glasgow-based MedTech startup, secured nearly €752k in funding. Gabriel Investment Syndicate led the round. This investment supports the company's AI-powered diagnostics for paediatric sleep disorders.

## Advancing Paediatric Sleep Diagnostics

The funding round included contributions from Scottish Enterprise, University of Strathclyde, and STAC Invest. Seluna develops an [artificial intelligence](https://www.startuphub.ai/ai-news/startup-news/2025/ai-math-the-silent-foundation-behind-artificial-intelligence-gets-a-10m-boost/) tool. This solution identifies and classifies digital biomarkers from sleep study data. It aims to tackle the underdiagnosis of childhood sleep apnoea, a condition often overlooked by broader AI diagnostics solutions.

Seluna launched an NHS validation study. This 500-patient trial takes place at the Royal Hospital for Children in Glasgow. The study validates Seluna’s proprietary Software as a Medical Device (SaMD). This technology uses machine-learning algorithms. It automatically analyses sleep study data, a process traditionally requiring manual interpretation.

The company's software addresses a condition affecting an estimated 96 million children globally. Approximately 80% of these children remain undiagnosed. While many [sleep technology](https://www.startuphub.ai/ai-news/funding-round/2025/somnee-secures-10-million-in-funding-to-revolutionize-sleep-technology/) companies focus on adult markets, Seluna's approach focuses on explainable AI for paediatric care. This builds trust for clinical use.

Seluna plans multi-site validation. Other NHS centres will join by year-end. The company targets UK Class I classification by late 2026. US FDA Class II approval is sought by 2027. This [MedTech](https://www.startuphub.ai/ai-news/funding-round/2025/irish-medtech-proverum-secures-e68-6m-for-bph-treatment/) innovation aims to set new standards.
---
Original analysis from [startuphub.ai](https://www.startuphub.ai), the #1 AI startup directory.